Efficacy of artificial femoral head replacement for femoral head avascular necrosis
| Autor: | Yan-Bao Li, Xue Yu, Peng Zhao, Xiao-Feng Qiao, Ji Qinghui, Shou-Feng Wang |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Arthroplasty Replacement Hip medicine.medical_treatment efficacy MEDLINE Cochrane Library law.invention Femoral head avascular necrosis 03 medical and health sciences Femoral head 0302 clinical medicine Meta-Analysis as Topic Randomized controlled trial Quality of life Femur Head Necrosis law Study Protocol Systematic Review Humans Medicine 030212 general & internal medicine avascular necrosis Randomized Controlled Trials as Topic business.industry artificial femoral head replacement femoral head General Medicine Knowledge infrastructure Arthroplasty medicine.anatomical_structure 030220 oncology & carcinogenesis randomized controlled trial Physical therapy Hip Prosthesis business Research Article Systematic Reviews as Topic |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 0025-7974 |
| DOI: | 10.1097/md.0000000000015411 |
| Popis: | Background: Femoral head avascular necrosis (FHAN) is one of the most common progressive orthopedic disorders. Previous studies have reported that artificial femoral head replacement (AFHR) can effectively treat patients with FHAN. However, no systematic review has investigated the efficacy of AFHR for FHAN. This study will assess the efficacy of AFHR for patients with FHAN. Methods: We will search MEDLINE, EMBASE, Web of Science, Cochrane Library, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure up to March 1, 2019 without any restrictions. Any randomized controlled trials for assessing the efficacy of AFHR for patients with FHAN. The methodological quality for each eligible study will be assessed by using Cochrane risk of bias tool. Statistical analysis will be conducted by using RevMan 5.3. Results: This study will provide current evidence of AFHR for patients with FHAN from several aspects, including pain intensity, function, and limitation of femoral head, health-related quality of life, and safety. Conclusion: This study will provide latest evidence on assessing the efficacy and safety of AFHR for FHAN. PROSPERO registration number: PROSPERO CRD42019126249. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|